Drug Makers Pleased by HHS Ruling on Copayment Assistance

The Wall Street Journal reports that the Administration sided with the pharmaceutical industry last week when HHS ruled that drug makers would be allowed to offer copayment assistance, or rebates, to patients who buy their brand-name prescription drugs and are covered by plans offered as part of the ACA’s exchanges. The assistance allows patients to purchase brand-name drugs at the same price of generic competitors. The Journal notes that such assistance is barred in the cases of Medicare and Medicaid beneficiaries who choose not to purchase generic drugs.

From the American Association for Justice news release.

This entry was posted in Medical & Health Resources or Issues. Bookmark the permalink.

Comments are closed.